Canada unveils plan to ban all crypto ATMs nationwide, citing fraud and money laundering. The move follows similar actions in the US, Australia, and beyond.
Browsing: News
Ethereum (ETH) trades near $2,300 as retail investors sell 756K ETH and whales accumulate 60K tokens. Key levels at $2,200 support and $2,400 resistance.
Judge Lewis Kaplan denied Sam Bankman-Fried’s motion for a new trial, calling his arguments baseless and conspiratorial in a Tuesday ruling.
XRP Ledger tokenized RWA value surges to $3 billion, up 59% in 30 days. XRP trades at $1.39 as analysts monitor critical support zones.
Paul Tudor Jones ranks bitcoin as the top inflation hedge over gold and cautions S&P 500 investors may face negative 10-year returns due to extreme valuations.
Bitcoin holds steady near $77K despite oil surging past $111 on Hormuz blockade fears. Major altcoins decline while BTC shows resilience to macro pressures.
Robinhood (HOOD) shares tumbled 9% after hours as Q1 earnings missed estimates with crypto revenue down 47% YoY, offset partly by prediction market growth.
ZunaBet replaces traditional casino points with transparent rakeback up to 20%. See why direct returns beat complex loyalty programs for regular players.
UnitedHealth (UNH) stock rises 3.6% after crushing Q1 estimates with $7.23 EPS and improved medical benefit ratio. Full analysis of earnings and outlook.
AMD stock dropped 4.8% Tuesday after reports showed OpenAI missed 2025 revenue targets, sparking concerns about AI chip demand for semiconductor companies.
Erasca (ERAS) stock plunged 50% after disappointing cancer drug trial data, a patient death, and a patent lawsuit from Revolution Medicines.
Cleveland-Cliffs (CLF) partners with Palantir Technologies (PLTR) for a three-year AI deployment across manufacturing operations and workflows.
Alphabet (GOOGL) withdrew from a $100M Pentagon drone program after ethics review, marking another clash between Google’s defense ambitions and employee concerns.
Micron (MU) receives bullish analyst calls with DA Davidson’s $1,000 target and TD Cowen’s $660 forecast, driven by AI memory demand and HBM share gains.
Gilead Sciences (GILD) wraps up $7.8B Arcellx deal, gaining CAR T-cell therapy control. Stock tests key support at $128 with oversold RSI signals.